What is new in chronic lymphocytic leukemia (CLL)? (Episode 4)
0 Views
administrator
07/08/23
The fixed-duration treatment with ibrutinib + venetoclax has been investigated in older patients and/or unfit patients with previously untreated chronic lymphocytic leukaemia (CLL) compared chlorambucil plus obinutuzumab.
phase 3 GLOW study results were published in ASH 2022 meeting. Dr. Ahmed Magdy summarized the major interesting results of this trial.
-
Category
Show more
Facebook Comments
No comments found